Dis-Chem Pharmacies (JSE:DCP) EBITDA Margin % : 5.12% (As of Aug. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Dis-Chem Pharmacies's EBITDA for the six months ended in Aug. 2023 was R915 Mil. Dis-Chem Pharmacies's Revenue for the six months ended in Aug. 2023 was R17,856 Mil. Therefore, Dis-Chem Pharmacies's EBITDA margin for the quarter that ended in Aug. 2023 was 5.12%.

Dis-Chem Pharmacies EBITDA Margin % Historical Data

The historical data trend for Dis-Chem Pharmacies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies EBITDA Margin % Chart

Dis-Chem Pharmacies Annual Data

Trend

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

EBITDA Margin %

Get a 7-Day Free Trial

8.81

7.70

7.57

7.92

8.54

Dis-Chem Pharmacies Semi-Annual Data
	Feb14	Feb15	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23
EBITDA Margin %	Get a 7-Day Free Trial														5.12	5.09	6.23	4.71	5.12

Competitive Comparison of Dis-Chem Pharmacies's EBITDA Margin %

For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dis-Chem Pharmacies's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Dis-Chem Pharmacies's EBITDA Margin % falls into.

Dis-Chem Pharmacies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Dis-Chem Pharmacies's EBITDA Margin % for the fiscal year that ended in Feb. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Feb. 2023 )	/	Revenue (A: Feb. 2023 )
	=	2789.279	/	32663.513
	=	8.54 %

Dis-Chem Pharmacies's EBITDA Margin % for the quarter that ended in Aug. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Aug. 2023 )	/	Revenue (Q: Aug. 2023 )
	=	914.779	/	17855.999
	=	5.12 %

Dis-Chem Pharmacies (JSE:DCP) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Dis-Chem Pharmacies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dis-Chem Pharmacies (JSE:DCP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685

Website

https://www.dischem.co.za

Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.